Co-Diagnostics - Co-Diagnostics joins fight against coronavirus with diagnostic test Co-Diagnostics' detection of infectious disease has led it to join the coronavirus fight with flagship test

The Utah company's in-vitro Logix Smart Coronavirus Disease 2019 (COVID-19) test kits are...

7 hours, 1 minute ago

The chase for cannabis profits: Three industry executives weigh in on why...

Proactive spoke to three firms that delivered positive results this quarter about their thoughts...

1 day ago
Deep dive

Matinas BioPharma advances the promise of heart-healthy omega-3 fatty acids

The New Jersey-based company's lead product candidate, MAT9001 is for the treatment of...

6 days, 8 hours ago
Deep dive

Zynerba's CBD skin gel Zygel offers a goldmine of therapies for Fragile X...

All eyes are on Zynerba's meeting with the FDA in the fourth quarter of 2020 to discuss pivotal...

6 days, 21 hours ago

XPhyto Therapeutics provides update on their oral film drug delivery...

XPhyto Therapeutics (CSE: XPHY-OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to provide a look at their German subsidiary, Vektor Pharma who is currently advancing two sublingual ODF development programs for the delivery of the active pharmaceutical ingredients. Rogers...

1 hour, 51 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.